Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Lpar2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR2 mRNA] | CTD | PMID:31150632 | 1,1-dichloroethene | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of LPAR2 mRNA | CTD | PMID:26682919 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LPAR2 promoter] | CTD | PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lpar2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LPAR2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LPAR2 mRNA | CTD | PMID:21296121 | 6-propyl-2-thiouracil | increases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of LPAR2 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of LPAR2 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of LPAR2 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of LPAR2 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of LPAR2 mRNA | CTD | PMID:33167477 | amitrole | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of LPAR2 mRNA | CTD | PMID:30047161 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of LPAR2 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of LPAR2 mRNA | CTD | PMID:33212167 | arsenous acid | decreases response to substance | EXP | | 6480464 | LPAR2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | azoxystrobin | decreases expression | EXP | | 6480464 | azoxystrobin results in decreased expression of LPAR2 mRNA | CTD | PMID:33512557 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in decreased methylation of LPAR2 promoter] more ... | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of LPAR2 mRNA | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of LPAR2 5' UTR and Benzo(a)pyrene results in decreased methylation of LPAR2 promoter | CTD | PMID:27901495 | bisphenol A | affects expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of LPAR2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LPAR2 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LPAR2 mRNA | CTD | PMID:34947998 | chlorpyrifos | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of LPAR2 mRNA | CTD | PMID:37019170 | copper atom | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of LPAR2 mRNA | CTD | PMID:30911355 | copper(0) | multiple interactions | EXP | | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of LPAR2 mRNA | CTD | PMID:30911355 | Cuprizon | increases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of LPAR2 mRNA | CTD | PMID:26577399 | deguelin | decreases expression | EXP | | 6480464 | deguelin results in decreased expression of LPAR2 mRNA | CTD | PMID:33512557 | dextran sulfate | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA | CTD | PMID:29950665 | diarsenic trioxide | decreases response to substance | EXP | | 6480464 | LPAR2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | diquat | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | Diquat results in increased expression of LPAR2 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA | CTD | PMID:27188386 | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA | CTD | PMID:19244175 | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of LPAR2 mRNA | CTD | PMID:16705744 | gentamycin | increases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of LPAR2 mRNA | CTD | PMID:33387578 | L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in decreased methylation of LPAR2 promoter] and Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of LPAR2 mRNA] | CTD | PMID:27901495 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of LPAR2 mRNA | CTD | PMID:28903495 | lipopolysaccharide | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of LPAR2 mRNA and Lipopolysaccharides results in increased expression of LPAR2 protein | CTD | PMID:21821728 | methimazole | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of LPAR2 mRNA | CTD | PMID:30047161 | methotrexate | affects response to substance | EXP | | 6480464 | LPAR2 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | Nor-9-carboxy-delta9-THC | multiple interactions | EXP | | 6480464 | [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LPAR2 gene | CTD | PMID:30521419 | ozone | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LPAR2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LPAR2 mRNA | CTD | PMID:34911549 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of LPAR2 mRNA | CTD | PMID:35430440 | PCB138 | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorohexanesulfonic acid | decreases expression | ISO | Lpar2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of LPAR2 mRNA | CTD | PMID:37995155 | phenobarbital | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Phenobarbital results in decreased expression of LPAR2 mRNA | CTD | PMID:30047161 | picoxystrobin | decreases expression | EXP | | 6480464 | picoxystrobin results in decreased expression of LPAR2 mRNA | CTD | PMID:33512557 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA | CTD | PMID:27188386 | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA | CTD | PMID:19244175 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of LPAR2 mRNA | CTD | PMID:31758290 | tetrachloroethene | increases expression | ISO | Lpar2 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of LPAR2 mRNA | CTD | PMID:28973375 | tetrachloromethane | decreases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of LPAR2 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | Lpar2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR2 mRNA] | CTD | PMID:31150632 | titanium dioxide | multiple interactions | ISO | Lpar2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA | CTD | PMID:29950665 | trichloroethene | increases expression | ISO | Lpar2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of LPAR2 mRNA | CTD | PMID:33387578 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of LPAR2 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of LPAR2 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA | CTD | PMID:27188386 | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA | CTD | PMID:19244175 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of LPAR2 mRNA | CTD | PMID:27188386 | |